ATE170075T1 - Antivirales arzneimittel enthaltend prostratin - Google Patents
Antivirales arzneimittel enthaltend prostratinInfo
- Publication number
- ATE170075T1 ATE170075T1 AT91910575T AT91910575T ATE170075T1 AT E170075 T1 ATE170075 T1 AT E170075T1 AT 91910575 T AT91910575 T AT 91910575T AT 91910575 T AT91910575 T AT 91910575T AT E170075 T1 ATE170075 T1 AT E170075T1
- Authority
- AT
- Austria
- Prior art keywords
- antiviral
- prostratin
- present
- product containing
- medicinal product
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title abstract 5
- NUQJULCGNZMBEF-UHFFFAOYSA-N Prostratin Natural products COC(=O)C12CC(C)C3(O)C(C=C(CO)CC4(O)C3C=C(C)C4=O)C1C2(C)C NUQJULCGNZMBEF-UHFFFAOYSA-N 0.000 title abstract 2
- BOJKFRKNLSCGHY-HXGSDTCMSA-N prostratin Chemical compound C1=C(CO)C[C@]2(O)C(=O)C(C)=C[C@H]2[C@@]2(O)[C@H](C)C[C@@]3(OC(C)=O)C(C)(C)[C@H]3[C@@H]21 BOJKFRKNLSCGHY-HXGSDTCMSA-N 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical class C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 abstract 1
- 230000000722 protumoral effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000002110 toxicologic effect Effects 0.000 abstract 1
- 231100000723 toxicological property Toxicity 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53056290A | 1990-05-30 | 1990-05-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE170075T1 true ATE170075T1 (de) | 1998-09-15 |
Family
ID=24114097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91910575T ATE170075T1 (de) | 1990-05-30 | 1991-05-24 | Antivirales arzneimittel enthaltend prostratin |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5599839A (de) |
| EP (1) | EP0531413B1 (de) |
| JP (1) | JPH0737380B2 (de) |
| AT (1) | ATE170075T1 (de) |
| AU (1) | AU639343B2 (de) |
| CA (1) | CA2083945C (de) |
| DE (1) | DE69130063T2 (de) |
| DK (1) | DK0531413T3 (de) |
| ES (1) | ES2120962T3 (de) |
| WO (1) | WO1991018595A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1924548B1 (de) | 2005-07-13 | 2018-03-28 | Salvia Sciences, Inc. | Ester-prodrugs von prostratin und verwandten phorbolverbindungen |
| US11696908B2 (en) | 2007-01-31 | 2023-07-11 | Biosuccess Biotech Co. Ltd. | Compositions and methods of use of phorbol esters |
| US9533938B2 (en) | 2007-01-31 | 2017-01-03 | Biosuccess Biotech Co., Ltd. | Compositions and methods of use of phorbol esters for the treatment of stroke |
| US9636317B2 (en) | 2007-01-31 | 2017-05-02 | Biosuccess Biotech Co. Ltd. | Compositions and methods of use of phorbol esters |
| US11564901B2 (en) | 2007-01-31 | 2023-01-31 | Biosuccess Biotech Co., Ltd. | Compositions and methods of use of phorbol esters |
| US9974764B2 (en) | 2007-01-31 | 2018-05-22 | Biosuccess Biotech Co. Ltd. | Compositions and methods of use of phorbol esters in the treatment of neoplasms |
| JP2010516813A (ja) | 2007-01-31 | 2010-05-20 | バイオサクセス バイオテック カンパニー | ホルボールエステルを含む組成物及びその使用法 |
| US10369222B2 (en) | 2012-01-18 | 2019-08-06 | Biosuccess Biotech Co., Ltd. | Compositions and methods of use of phorbol esters for the treatment of stroke |
| US8067632B2 (en) | 2007-07-26 | 2011-11-29 | The Board Of Trustees Of The Leland Stanford Junior University | Process to produce prostratin and structural or functional analogs thereof |
| EP2276478A4 (de) * | 2008-04-11 | 2012-03-07 | Aids Res Alliance | Verfahren zur verabreichung von prostratin und strukturellen analoga davon |
| US20100298171A1 (en) * | 2009-05-22 | 2010-11-25 | Affymetrix, Inc. | Apparatus for polymer synthesis |
| WO2011014561A1 (en) * | 2009-07-29 | 2011-02-03 | He Johnny J | Extracts of medicinal plant and uses thereof |
| US9550722B2 (en) | 2012-01-18 | 2017-01-24 | Biosuccess Biotech Co. Ltd. | Compositions and methods of use of phorbal esters for the treatment of stroke |
| US10099996B2 (en) | 2012-01-18 | 2018-10-16 | Biosuccess Biotech Co. Ltd. | Compositions and methods of use of phorbol esters in the treatment of neoplasms |
| ITUB20153575A1 (it) * | 2015-09-11 | 2017-03-11 | Fca Italy Spa | "Sospensione per una ruota sterzante di autoveicolo, con asse di sterzo semi-virtuale" |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4902716A (en) * | 1984-12-18 | 1990-02-20 | Harbor Branch Oceanographic Institutuion, Inc. | Anti-viral chamigrene derivatives |
-
1991
- 1991-05-24 DE DE69130063T patent/DE69130063T2/de not_active Expired - Lifetime
- 1991-05-24 ES ES91910575T patent/ES2120962T3/es not_active Expired - Lifetime
- 1991-05-24 JP JP3510273A patent/JPH0737380B2/ja not_active Expired - Lifetime
- 1991-05-24 EP EP91910575A patent/EP0531413B1/de not_active Expired - Lifetime
- 1991-05-24 CA CA002083945A patent/CA2083945C/en not_active Expired - Lifetime
- 1991-05-24 DK DK91910575T patent/DK0531413T3/da active
- 1991-05-24 AU AU79099/91A patent/AU639343B2/en not_active Expired
- 1991-05-24 AT AT91910575T patent/ATE170075T1/de not_active IP Right Cessation
- 1991-05-24 WO PCT/US1991/003619 patent/WO1991018595A1/en not_active Ceased
-
1995
- 1995-04-17 US US08/424,558 patent/US5599839A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69130063D1 (de) | 1998-10-01 |
| EP0531413B1 (de) | 1998-08-26 |
| JPH05506451A (ja) | 1993-09-22 |
| WO1991018595A1 (en) | 1991-12-12 |
| CA2083945C (en) | 1995-02-07 |
| AU639343B2 (en) | 1993-07-22 |
| DK0531413T3 (da) | 1999-05-25 |
| AU7909991A (en) | 1991-12-31 |
| ES2120962T3 (es) | 1998-11-16 |
| DE69130063T2 (de) | 1999-02-25 |
| EP0531413A1 (de) | 1993-03-17 |
| US5599839A (en) | 1997-02-04 |
| JPH0737380B2 (ja) | 1995-04-26 |
| EP0531413A4 (en) | 1993-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MD1224B2 (en) | Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B | |
| ATE170075T1 (de) | Antivirales arzneimittel enthaltend prostratin | |
| FI862011A0 (fi) | Terapeutiska nukleosider. | |
| DE69333321D1 (de) | Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten. | |
| EP0513702A3 (de) | Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie | |
| TW250435B (de) | ||
| IT1256450B (it) | Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione | |
| ATE197670T1 (de) | Parenterales busulfan zur behandlung von malignen krankheiten | |
| AU3951389A (en) | The use of alpha-amino boronicacid derivatives for the prophylaxis and treatment of virus diseases | |
| HU907654D0 (en) | Process for the production of medical preparations with increased stabilization, and without tissue-harming effect | |
| MY108146A (en) | Medicaments for treating inflammatory conditions or for analgesia | |
| AU1976183A (en) | N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives | |
| IL88971A0 (en) | Disubstituted pyridines,their preparation and pharmaceutical compositions containing them | |
| CA2094275A1 (en) | Methods and compositions for the treatment of cell proliferation disorders | |
| HU9200438D0 (en) | Process for the production of novel cumarin derivatives and their analogues preventing tumor-growth and cell-proliferation in mammals, and of medical preparations containing them | |
| IL97054A0 (en) | Pharmaceutical compositions comprising buspirones for the treatment of sleep apneas | |
| HU9201358D0 (en) | 2-amino-pirimidine-4-carboxamide derivatives, process for their production and for the production of medical preparations containing them as active agents | |
| CA2255856A1 (en) | Therapeutic uses for an aminosterol compound | |
| IL111138A (en) | Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia | |
| AU1447892A (en) | Pharmaceutical preparations for the therapy of tumors containing colchicine as the active principle and methods for the use of the same | |
| ATE137968T1 (de) | Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen | |
| EP0459176A3 (en) | Oligophosphates with antiviral activity | |
| ATE210445T1 (de) | Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen | |
| EP0132772A3 (en) | Fr-900216 substance obtainable by cultivating atcc 20577 for use as an active therapeutic substance and pharmaceutical antitumor composition comprising fr-900216 substance | |
| AP9200405A0 (en) | Pharmaceutical formulations comprised of micronised halofantrine. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EELA | Cancelled due to lapse of time |